**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7791-20-0 |Nickel (II) Chloride Hexahydrate | >97% | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 25 20
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic if swallowed. Harmful by inhalation.Toxic.
Potential Health Effects
Eye:
May cause eye irritation and possible burns.
Skin:
Contact with skin causes irritation and possible burns, especially
if the skin is wet or moist. May cause severe irritation and possible
burns. May cause dermatitis. Causes "nickel itch" which is a
dermatitis resulting from sensitization to nickel, which is
characterized by skin eruptions, followed by discrete ulcers that
may discharge and become crusted, or by eczema.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with
nausea, vomiting and diarrhea.
Inhalation:
Inhalation of a mist of this material may cause respiratory tract
irritation.
Chronic:
Prolonged or repeated skin contact may cause sensitization
dermatitis and possible destruction and/or ulceration. May cause
respiratory tract cancer. Symptoms of overexposure to nickel can
cause sensitization, dermatitis, allergic asthma and pneumonitis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately. Do NOT allow victim to rub eyes or keep eyes closed.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Water runoff can cause environmental damage. Dike
and collect water used to fight fire. During a fire, irritating and
highly toxic gases may be generated by thermal decomposition or
combustion.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Reduce airborne dust and prevent scattering by moistening
with water. Clean up spills immediately, observing precautions in
the Protective Equipment section. Avoid generating dusty conditions.
Carefully scoop up and place into appropriate disposal container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with skin and eyes. Avoid
ingestion and inhalation.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7791-20-0:
United States OSHA: 1 mg/m3 TWA (as Ni) (listed under Nickel sol
compounds).
Belgium - TWA: (listed as nickel soluble compounds): 0.1 mg/m3 VL
(as Ni)
Malaysia: (listed as nickel soluble compounds): 0.1 mg/m3 TWA
(inhalable fraction, as Ni)
Netherlands: (listed as nickel soluble compounds): 0.1 mg/m3 MAC
Ni)
Spain: (listed as nickel soluble compounds): 0.1 mg/m3 VLA-ED (as
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: green
Odor: odorless
pH: 4.0 (aqueous sol)
Vapor Pressure: 1 mm Hg @1140F
Viscosity: Not available.
Boiling Point: 1783 deg F
Freezing/Melting Point: Not available.
Autoignition Temperature: Noncombustible.
Flash Point: Noncombustible.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Soluble.
Specific Gravity/Density: 3.55 (water=1)
Molecular Formula: NiCl2.6H2O
Molecular Weight: 237.6764
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong acids, peroxides, potassium.
Hazardous Decomposition Products:
Hydrogen chloride, nickel oxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7791-20-0: QR6480000
LD50/LC50:
CAS# 7791-20-0: Oral, rat: LD50 = 105 mg/kg.
Carcinogenicity:
Nickel (II) Chloride Hexahydrate -
California: carcinogen, initial date 5/7/04 (listed as Nickel compound
NTP: Known carcinogen (listed as Nickel compounds).
IARC: Group 1 carcinogen (listed as Nickel compounds).
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3288
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3288
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3288
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 20 Harmful by inhalation.
R 25 Toxic if swallowed.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 7791-20-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 7791-20-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7791-20-0 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/18/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Triethanolamine, 99+% (titr.)
| 102-71-6 |
|
Benzopinacole, 98%
| 464-72-2 |
|
N,N-Diethyl-p-phenylenediamine oxalate, 96%
| 62637-92-7 |
|
Nalidixic acid, 99.5%
| 389-08-2 |
|
(R)-(+)-N-Allyl-1-phenylethylamine hydrochloride
| 37696-17-6 |
|
Divinyltetramethyldisiloxane, 97%
| 2627-95-4 |
|
Tetraethyl orthosilicate, 95%
| 78-10-4 |
|
1,2-Epoxyhexane, 97%
| 1436-34-6 |
|
(N-Acetyl)-(2R)-bornane-10,2-sultam
| 141993-16-0 |
|
Naphthalene, scintillation grade, 99+%
| 91-20-3 |
|
Nickel Spheres, p.a., 6 to 16mm
| 7440-02-0 |
|
(1R,2R)-N,N'-Di-p-toluenesulfonyl-1,2-diphenyl-1,2-ethylenediamine
| 121758-19-8 |
|
Nickel Acetate Tetrahydrate, Reagent (Crystals), 99% (Titr.)
| 6018-89-9 |
|
(1S,2S)-N,N'-Di-p-toluenesulfonyl-1,2-diphenyl-1,2-ethylenediamine
| 170709-41-8 |
|
(N-Acetyl)-(4R)-benzyl-2-oxazolidinone, 99%
| 132836-66-9 |
|
(N-Crotonyl)-(4S)-isopropyl-2-oxazolidinone
| 90719-30-5 |
|
(N-Crotonyl)-(4S)-benzyl-2-oxazolidinone
| 0-01-1 |
|
(S)-PHENYL SUPERQUAT, 98%
| 0-01-1 |
|
(R)-PHENYL SUPERQUAT, 98%
| 0-01-1 |
|
Forskolin
| 66575-29-9 |
|
Fumonisin B2
| 0-01-1 |
|
Genistein (synthetic), 99%
| 446-72-0 |
|
Nickel (II) Chloride Hexahydrate, 97%
| 7791-20-0 |
|
H-7.dihydrochloride
| 108930-17-2 |
|
Nickel(II) Nitrate Hexahydrate 99%
| 13478-00-7 |
|
H-8, dihydrochloride
| 113276-94-1 |
|
P-Phenylenediacrylic Acid, 97%
| 16323-43-6 |
|
Nickel Monoxide, Peagent (Powder), 97% (titr.)
| 1313-99-1 |
|
N-(2-Hydroxyethyl)ethylenediaminetriacetic acid, trisodium salt
| 0-00-1 |
|
Ammonium Bicarbonate
| 1066-33-7 |
|
H-89.dihydrochloride
| 127243-85-0 |
|
K-252a
| 97161-97-2 |
|
2-N-Butylaminoethanethiol
| 5842-00-2 |
|
KN-62
| 127191-97-3 |
|
KN-93
| 0-01-1 |
|
Lavendustin A
| 125697-92-9 |
|
Leupeptin (synthetic)
| 24365-46-6 |
|
Nickel Sulfate Hexahydrate, Reagent ACS (Crystals)
| 10101-97-0 |
|
Methyl caffeate
| 3843-74-1 |
|
Ammonium Bifluoride
| 1341-49-7 |
|
Okadaic acid (high purity)
| 78111-17-8 |
|
Okadaic acid ammonium salt (high purity)
| 155716-06-6 |
|
Okadaic acid potassium salt (high purity )
| 155751-72-7 |
|
Okadaic acid sodium salt (high purity)
| 78111-17-8 |
|
Olomoucine (high purity)
| 101622-51-9 |
|
Paclitaxel, 99+%
| 33069-62-4 |
|
Pentoxifylline
| 6493-05-6 |
|
Phorbol 12-myristate 13-acetate, 99%
| 16561-29-8 |
|
Piceatannol
| 10083-24-6 |
|
Resiniferatoxin (high purity)
| 57444-62-9 |
|
|